Maher, Steven P.
Vantaux, Amélie
Chaumeau, Victor
Chua, Adeline C. Y.
Cooper, Caitlin A.
Andolina, Chiara
Péneau, Julie
Rouillier, Mélanie
Rizopoulos, Zaira
Phal, Sivchheng
Piv, Eakpor
Vong, Chantrea
Phen, Sreyvouch
Chhin, Chansophea
Tat, Baura
Ouk, Sivkeng
Doeurk, Bros
Kim, Saorin
Suriyakan, Sangrawee
Kittiphanakun, Praphan
Awuku, Nana Akua
Conway, Amy J.
Jiang, Rays H. Y.
Russell, Bruce
Bifani, Pablo
Campo, Brice
Nosten, François
Witkowski, Benoît
Kyle, Dennis E.
Funding for this research was provided by:
Medicines for Malaria Venture (RD/2015/0022, RD/2017/0042, RD/2017/0042, RD/2015/0022)
Wellcome Trust (220211, 220211)
National University Health System (WBS R-571-000-040-133)
Bill and Melinda Gates Foundation (OPP1023601)
Article History
Received: 29 January 2021
Accepted: 21 September 2021
First Online: 7 October 2021
Competing interests
: B.C, M.R., and Z.R. are employees of MMV, the other authors declare no potential conflict of interest.